β-Arrestin1 regulates γ-secretase complex assembly and modulates amyloid-β pathology

Cell Research

Volumn 23, Issue 3, 2013, Pages 351-365

  Liu, Xiaosong ^a   Zhao, Xiaohui ^a   Zeng, Xianglu ^a   Bossers, Koen ^c   Swaab, Dick F ^c   Zhao, Jian ^a,b   Pei, Gang ^a,c,d  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^d TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BETA ARRESTIN; RETINA S ANTIGEN; SECRETASE;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; MOUSE MUTANT; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ARRESTINS; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE;

MUS;

EID: 84874650875     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2012.167     Document Type: Article

References (48)

1. Goedert M, Spillantini MG. A century of Alzheimer's disease. Science 2006; 314:777-781.
2. Amaducci L, Tesco G. Aging as a major risk for degenerative diseases of the central nervous system. Curr Opin Neurol 1994; 7:283-286.
3. Cohen E, Paulsson JF, Blinder P, et al. Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell 2009; 139:1157-1169.
4. Ritchie K, Lovestone S. The dementias. Lancet 2002; 360:1759-1766.
5. Braak H, Braak E. Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol 1991; 82:239-259.
6. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297:353-356.
7. Ballatore C, Lee VM, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 2007; 8:663-672.
8. Roberson ED, Mucke L. 100 years and counting: prospects for defeating Alzheimer's disease. Science 2006; 314:781-784.
9. Takasugi N, Tomita T, Hayashi I, et al. The role of presenilin cofactors in the gamma-secretase complex. Nature 2003; 422:438-441.
10. De Strooper B, Annaert W, Cupers P, et al. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 1999; 398:518-522.
11. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 2004; 101:2173-2178.
12. Teng L, Zhao J, Wang F, Ma L, Pei G. A GPCR/secretase complex regulates beta-and gamma-secretase specificity for Abeta production and contributes to AD pathogenesis. Cell Res 2010; 20:138-153.
13. Ni Y, Zhao X, Bao G, et al. Activation of beta2-adrenergic receptor stimulates gamma-secretase activity and accelerates amyloid plaque formation. Nat Med 2006; 12:1390-1396.
14. Thathiah A, Spittaels K, Hoffmann M, et al. The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons. Science 2009; 323:946-951.
15. El Khoury J, Toft M, Hickman SE, et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 2007; 13:432-438.
16. Bossers K, Wirz KT, Meerhoff GF, et al. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. Brain 2010; 133:3699-3723.
17. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. Beta-arrestins and cell signaling. Annu Rev Physiol 2007; 69:483-510.
18. Lefkowitz RJ. G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J Biol Chem 1998; 273:18677-18680.
19. Attramadal H, Arriza JL, Aoki C, et al. Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J Biol Chem 1992; 267:17882-17890.
20. Grady EF. Cell signaling. Beta-arrestin, a two-fisted terminator. Science 2007; 315:605-606.
21. Wakabayashi T, Craessaerts K, Bammens L, et al. Analysis of the gamma-secretase interactome and validation of its association with tetraspanin-enriched microdomains. Nat Cell Biol 2009; 11:1340-1346.
22. Karlstrom H, Bergman A, Lendahl U, Naslund J, Lundkvist J. A sensitive and quantitative assay for measuring cleavage of presenilin substrates. J Biol Chem 2002; 277:6763-6766.
23. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999; 285:1569-1572.
24. Nyabi O, Bentahir M, Horre K, et al. Presenilins mutated at Asp-257 or Asp-385 restore Pen-2 expression and Nicastrin glycosylation but remain catalytically inactive in the absence of wild type Presenilin. J Biol Chem 2003; 278:43430-43436.
25. Hu Y, Fortini ME. Different cofactor activities in gammasecretase assembly: evidence for a nicastrin-Aph-1 subcomplex. J Cell Biol 2003; 161:685-690.
26. LaVoie MJ, Fraering PC, Ostaszewski BL, et al. Assembly of the gamma-secretase complex involves early formation of an intermediate subcomplex of Aph-1 and nicastrin. J Biol Chem 2003; 278:37213-37222.
27. Fraering PC, LaVoie MJ, Ye W, et al. Detergent-dependent dissociation of active gamma-secretase reveals an interaction between Pen-2 and PS1-NTF and offers a model for subunit organization within the complex. Biochemistry 2004; 43:323-333.
28. Capell A, Beher D, Prokop S, et al. Gamma-secretase complex assembly within the early secretory pathway. J Biol Chem 2005; 280:6471-6478.
29. Herreman A, Serneels L, Annaert W, Collen D, Schoonjans L, De Strooper B. Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. Nat Cell Biol 2000; 2:461-462.
30. De Strooper B, Annaert W. Novel research horizons for presenilins and gamma-secretases in cell biology and disease. Annu Rev Cell Dev Biol 2010; 26:235-260.
31. Bammens L, Chavez-Gutierrez L, Tolia A, Zwijsen A, De Strooper B. Functional and topological analysis of Pen-2, the fourth subunit of the gamma-secretase complex. J Biol Chem 2011; 286:12271-12282.
32. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 2001; 17:157-165.
33. Conner DA, Mathier MA, Mortensen RM, et al. beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation. Circ Res 1997; 81:1021-1026.
34. Serneels L, Van Biervliet J, Craessaerts K, et al. gamma-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer's disease. Science 2009; 324:639-642.
35. Jorissen E, De Strooper B. Gamma-secretase and the intramembrane proteolysis of Notch. Curr Top Dev Biol 2010; 92:201-230.
36. Dudal S, Krzywkowski P, Paquette J, et al. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice. Neurobiol Aging 2004; 25:861-871.
37. Kaether C, Schmitt S, Willem M, Haass C. Amyloid precursor protein and Notch intracellular domains are generated after transport of their precursors to the cell surface. Traffic 2006; 7:408-415.
38. Spasic D, Raemaekers T, Dillen K, et al. Rer1p competes with APH-1 for binding to nicastrin and regulates gamma-secretase complex assembly in the early secretory pathway. J Cell Biol 2007; 176:629-640.
39. Chen F, Hasegawa H, Schmitt-Ulms G, et al. TMP21 is a presenilin complex component that modulates gammasecretase but not epsilon-secretase activity. Nature 2006; 440:1208-1212.
40. Bevins RA, Besheer J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nat Protoc 2006; 1:1306-1311.
41. Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 2006; 1:848-858.
42. Rozmahel R, Huang J, Chen F, et al. Normal brain development in PS1 hypomorphic mice with markedly reduced g-secretase cleavage of bAPP. Neurobiol Aging 2002; 23:187-194.
43. Oddo S, Caccamo A, Green KN, et al. Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc Natl Acad Sci USA 2005; 102:3046-3051.
44. Ni Y, Zhao X, Bao G, et al. Activation of b2-adrenergic receptor stimulates g-secretase activity and accelerates amyloid plaque formation. Nat Med 2006; 12:1390-1396.
45. Komano H, Seeger M, Gandy S, Wang GT, Krafft GA, Fuller RS. Involvement of cell surface glycosyl-phosphatidylinositollinked aspartyl proteases in a-secretase-type cleavage and ectodomain solubilization of human Alzheimer b-amyloid precursor protein in yeast. J Biol Chem 1998; 273:31648-31651.
46. Gruninger-Leitch F, Schlatter D, Kung E, Nelbock P, Dobeli H. Substrate and inhibitor profile of BACE (b-secretase) and comparison with other mammalian aspartic proteases. J Biol Chem 2002; 277:4687-4693.
47. Kakuda N, Funamoto S, Yagishita S, et al. Equimolar production of amyloid beta-protein and amyloid precursor protein intracellular domain from beta-carboxyl-terminal fragment by gamma-secretase. J Biol Chem 2006; 281:14776-14786.
48. Wittig I, Braun HP, Schagger H. Blue native PAGE. Nat Protoc 2006; 1:418-428.